J-shaped association between LDL cholesterol and cardiovascular events: A longitudinal primary prevention cohort of over 2.4 million people nationwide-Reference-Cited by-同舟云学术

J-shaped association between LDL cholesterol and cardiovascular events: A longitudinal primary prevention cohort of over 2.4 million people nationwide

Published:2023-05 Issue: Volume: Page:
ISSN:2090-1232
Container-title:Journal of Advanced Research
language:en
Short-container-title:Journal of Advanced Research

Author:

Park Chan Soon,Yang Han-Mo^ORCID,Han Kyungdo,Lee Hee-Sun,Kang Jeehoon,Han Jung-Kyu,Park Kyung Woo,Kang Hyun-Jae,Koo Bon-Kwon,Kim Hyo-Soo

Funder

Ministry of Science, ICT and Future Planning

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference55 articles.

1. Heart disease and stroke statistics-2021 update: a report from the American Heart Association;Virani;Circulation,2021

2. Epidemiology of cardiovascular disease in Europe;Townsend;Nat Rev Cardiol,2022

3. Stroke incidence and mortality trends in US communities, 1987 to 2011;Koton;JAMA,2014

4. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel;Borén;Eur Heart J,2020

5. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes;Cannon;N Engl J Med,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating Hypercholesterolemia in Older Adults for Primary Prevention of Cardiovascular Events;Drugs & Aging;2024-08-10

2. A genome-wide association study of high-sensitivity C-reactive protein in a large Korean population highlights its role in cholesterol metabolism;2024-06-28

3. Ketogenic Diets Hold Therapeutic Potential Against Periodontal Inflammation;Current Oral Health Reports;2024-04-27

4. Curcumin-Based Fixed Dose Combination Products for Cholesterol Management: A Narrative Review;ACS Pharmacology & Translational Science;2024-01-09

5. Improving a Patient’s CVD Risk Assessment—Updating the Interpretation of the Lipid Profile;World Journal of Cardiovascular Diseases;2024